期刊文献+

左旋肉碱对慢性肾功能衰竭血液透析患者臂肌围的影响 被引量:1

Effect of L-carnitine therapy on mid-arm muscle circumference of main tenance hemodialysis patients
原文传递
导出
摘要 目的评价应用左旋卡尼汀治疗的维持性血液透析(血透)患者的营养状况。方法采用随机、对照的研究方法,选择维持性血透患者66例,分为治疗组33例和对照组33例,每次透析结束后,治疗组静脉滴注左旋卡尼汀1g,对照组静脉滴注生理盐水2ml,连续3个月。结果治疗组干体质量、血红蛋白和上臂肌围值明显高于对照组(P<0.05)。结论左旋卡尼汀治疗的维持性血透患者营养状况明显优于未治疗者。 Objective To assess the nutritional status of maintenance hemodialysis patients treated with L - carnitine. Methods sixty - six maintenance hemodialysis patients were randomly divided into two groups : treatment group ( n = 33 ) and control group ( n = 33 ). In the treatment group, 1 g L -carnitine was given to the patients at the end of each dialysis treatment,the patients in the control group were given normal saline, and the treatment period was 3 months. Results Dry bodyweight, hemoglobin and mid - arm muscle circumference of the treatment group were elevated significantly ( P 〈 0.05 ). Conclusion Nutritional status of maintenance hemodialysis patients treated with L - carnitine are better than those of patients without L - camitine.
作者 韦建新
出处 《临床医学》 CAS 2009年第6期10-11,共2页 Clinical Medicine
关键词 血液透析 左旋肉碱 营养状况 Hemodialysis L - carnitine Nutrition status
  • 引文网络
  • 相关文献

参考文献8

二级参考文献56

  • 1Thompson CH,Irish AB,Kemp GJ,et al.The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.Clin Nephol,1997,47:372-377.
  • 2Wanner C,Hori WH.Carnitine abnormalities in patients with renal insufficiency:pathophysiological and therapeutic aspects.Nephron,1988,50(2):89-102.
  • 3[1]Josef Kcetzmayr, Gert Mayer, Elisabeth Legenstein, et al. Anemia and carnitine supplementation in hemodialyzed patients.Kidney International,1999,55 (suppl 69): s93-s106
  • 4[2]Alhomida A.S, Sobki S.H, Al Sulaiman, et al .Influence of sex and chronic haemodialysis treatment on total ,free and acyl carnitine concentrations in human serum. International Urology and Nephrology, 1997,29(4): 479-487
  • 5[3]Debska S, Kawecka A, Wojnarowski K, et al. Correlation between plasma caZrnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients.Int-T-Artif -Organs,2000,23(2):90-96
  • 6[4]Allan M, Evans. Pharmacokinetics of L-carnitine in patients with end stage renal disease undergoing long-term hemodialysis. Clinical Pharmacology and Therapeurics,2000, 68(3): 238-240
  • 7[5]Nikolaos S,Goerge A,Telemachos T, et al. Effects of L-carnitine supplement on red blood cells deformation in hemodialysis patients .Renal Failure, 2000,22(1):73-80
  • 8[6]Matsumura M ,Hatakeyama S, Koni I,et al.Carnitine between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron, 1996,72:574-578
  • 9[7]Reyes B, Navarro J.A, Perez R,et al. Effects of L-carnitine on erythrocyte acy1-CoA,free CoA, and glycerophospholipid acyltrasferase in uremia. Am-J-Clin-Nutr, 1998, 67(3) :386-390
  • 10[8]Pangoli L.G, Palmieri G, Mmriello A, et al. Morphometric evidence of traphic effect of L-carnitine on human sketetal muscle. Nephron,1990,56:16-23

共引文献492

同被引文献6

二级引证文献9

;
使用帮助 返回顶部